Immunology and Microbiology
Influenza
100%
Vaccine Efficacy
92%
Influenza Vaccine
60%
Vaccination Policy
58%
Virosome
35%
Immunogenicity
31%
Immune Response
29%
Virus Inactivation
28%
Mouse
25%
Influenza Virus
25%
Cytotoxic T Cell
24%
Subunit Vaccine
22%
Adoptive Immunity
19%
Adjuvant
19%
T Cell
18%
Antibody Response
17%
COVID-19
14%
Influenza A Virus (H5N1)
14%
Influenza A Virus (H1N1)
12%
Dendritic Cell
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Inactivated Virus Vaccine
12%
Antigen
11%
Peripheral Blood Mononuclear Cell
11%
Nucleoprotein
9%
Membrane Fusion
9%
Humoral Immunity
9%
Systemic Lupus Erythematosus
9%
Neutralizing Antibody
8%
Monospecific Antibody
8%
Titer
8%
Viral Disease
8%
Dry Powder
7%
Viral Envelope
7%
Heat Shock
7%
Granulomatosis with Polyangiitis
7%
Hemagglutinin
7%
MHC Class I
6%
Toll-Like Receptor
6%
Antibody Titer
6%
Hemagglutination Inhibition
6%
Immunotherapy
6%
Antigen-Presenting Cell
6%
B Cell
6%
Virus Strain
6%
interferon
5%
Influenza A Virus (H3N2)
5%
Cross Protection
5%
Phosphoryl Lipid A
5%
Surface Property
5%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza Vaccine
47%
Vaccination Policy
40%
Mouse
31%
Live Attenuated Influenza Vaccine
28%
Virosome
28%
Immunogenicity
26%
Adjuvant
25%
Subunit Vaccine
24%
Influenza Virus
21%
Infection
15%
Inactivated Virus Vaccine
13%
SARS Coronavirus
12%
Powder Formulation
12%
Influenza A Virus (H5N1)
10%
Inulin
10%
Antigen
10%
Disease
8%
Bagg Albino Mouse
8%
Trehalose
8%
Respiratory Tract
8%
Hemagglutinin
7%
Influenza A (H5N1)
7%
Saponin
6%
Immunoglobulin A
6%
Phosphoryl Lipid A
5%
Antivirus Agent
5%
Influenza A Virus (H1N1)
5%
Normal Human
5%
Keyphrases
Influenza Vaccine
17%
Influenza
11%
Influenza Vaccination
10%
Whole Inactivated Virus
8%
Lung
6%
Virus
6%
Immune Response
6%
Vaccination
5%
